News - Pro Anima

2 July 2024

Institut Curie spin-off for Personalized Cancer Treatment, Join ECHA in bridging the gap between science and regulation, Chimeroids as a scalable system for high-throughput investigation and more

NEWS, REPORTS & POSITION STATEMENTS 1. Scientists committed to revolutionize chemical safety testing met in Brussels Leading scientists from Europe and North America convened in Brussels in June to chart a future for chemical safety testing that prioritizes ethics, accuracy, […]

26 June 2024

CHANGE : accelerate the effective use of NAMs in regulatory toxicology, Model Master Files, Literature for animal testing alternatives, and more

NEWS, REPORTS & POSITION STATEMENTS 1. Lab-grown tumours predict treatment outcomes in landmark study Bowel cancer, also known as colorectal cancer, remains the second leading cause of cancer-related deaths worldwide. A world-first study, led by WEHI researchers and published in […]

20 June 2024

Novel Facility for Manufacturing Patient-Derived Organoids, AI or Liver MPS to Revolutionize Drug Development & Safety Assessment, and more

NEWS, REPORTS & POSITION STATEMENTS 1. Using AI to Predict the Probability of Success in Drug Development Artificial intelligence (AI) is one of the latest tools deployed to reduce costs and increase drug discovery, security assessment and development productivity. AI […]

10 June 2024

DVES 2025 Prize — Call for application, The race for AI-discovered drugs, OrganoIDNet : deep learning and organoids to treat pancreatic cancer, and more

NEWS, REPORTS & POSITION STATEMENTS 1. Big Pharma steps up race for AI-discovered drugs Pharmaceutical giants, including Swiss firms Roche and Novartis, are betting big on artificial intelligence to discover new drugs to treat a range of diseases. AI’s potential […]

5 June 2024

FDA Using OoC Technology, French Senator to Request The Use of Liver-Chip For the Preclinical Stage, New Universal Animal Product-free Medium, and more

NEWS, REPORTS & POSITION STATEMENTS 1. Latest British Toxicology Society (BTS) Public Statement New Approach Methodologies (NAMs) collectively refer to technology-enabled strategies for obtaining information about the toxicity of chemicals without relying on traditional animal testing. These strategies have the […]

Pour offrir les meilleures expériences, nous utilisons des technologies telles que les cookies pour stocker et/ou accéder aux informations des appareils. Le fait de consentir à ces technologies nous permettra de traiter des données telles que le comportement de navigation ou les ID uniques sur ce site. Le fait de ne pas consentir ou de retirer son consentement peut avoir un effet négatif sur certaines caractéristiques et fonctions.

Fonctionnel Always active

Le stockage ou l’accès technique est strictement nécessaire dans la finalité d’intérêt légitime de permettre l’utilisation d’un service spécifique explicitement demandé par l’abonné ou l’internaute, ou dans le seul but d’effectuer la transmission d’une communication sur un réseau de communications électroniques.

Preferences

The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.

Statistiques

The technical storage or access that is used exclusively for statistical purposes. Le stockage ou l’accès technique qui est utilisé exclusivement dans des finalités statistiques anonymes. En l’absence d’une assignation à comparaître, d’une conformité volontaire de la part de votre fournisseur d’accès à internet ou d’enregistrements supplémentaires provenant d’une tierce partie, les informations stockées ou extraites à cette seule fin ne peuvent généralement pas être utilisées pour vous identifier.

Marketing

Le stockage ou l’accès technique est nécessaire pour créer des profils d’internautes afin d’envoyer des publicités, ou pour suivre l’internaute sur un site web ou sur plusieurs sites web ayant des finalités marketing similaires.

Non Animal methods

2 July 2024
Institut Curie spin-off for Personalized Cancer Treatment, Join ECHA in bridging the gap between science and regulation, Chimeroids as a scalable system for high-throughput investigation and more

26 June 2024
CHANGE : accelerate the effective use of NAMs in regulatory toxicology, Model Master Files, Literature for animal testing alternatives, and more

20 June 2024
Novel Facility for Manufacturing Patient-Derived Organoids, AI or Liver MPS to Revolutionize Drug Development & Safety Assessment, and more

10 June 2024
DVES 2025 Prize — Call for application, The race for AI-discovered drugs, OrganoIDNet : deep learning and organoids to treat pancreatic cancer, and more

5 June 2024
FDA Using OoC Technology, French Senator to Request The Use of Liver-Chip For the Preclinical Stage, New Universal Animal Product-free Medium, and more

Support non-animal research

Sciences Enjeux Santé

Non Animal methods

2 July 2024Institut Curie spin-off for Personalized Cancer Treatment, Join ECHA in bridging the gap between science and regulation, Chimeroids as a scalable system for high-throughput investigation and more

26 June 2024CHANGE : accelerate the effective use of NAMs in regulatory toxicology, Model Master Files, Literature for animal testing alternatives, and more

20 June 2024Novel Facility for Manufacturing Patient-Derived Organoids, AI or Liver MPS to Revolutionize Drug Development & Safety Assessment, and more

10 June 2024DVES 2025 Prize — Call for application, The race for AI-discovered drugs, OrganoIDNet : deep learning and organoids to treat pancreatic cancer, and more

5 June 2024FDA Using OoC Technology, French Senator to Request The Use of Liver-Chip For the Preclinical Stage, New Universal Animal Product-free Medium, and more